Karen is the Global Lead for Patient Partnerships at Envision Pharma Group and oversees staff in Envision’s Tokyo and Sydney offices. She has 30 years of experience in the healthcare sector, gained in academia, hospital, industry (Pfizer, Johnson & Johnson), and agency (ProScribe Medical Communications, Envision Pharma Group) environments, in North America and the Asia Pacific region. Karen has a strong focus on strategic initiatives in the medical affairs sector and has led international teams to conduct and publish research on publications ethics and on patient engagement and involvement in industry-sponsored research. Karen is a Professor at two universities and has been a government-appointed director overseeing 6 hospitals, serving on the Patient Safety and Quality Committee, and managing a $2B budget. She was the inaugural chair of the Asia Pacific Advisory Committee for the International Society of Medical Publication Professionals, is an Honorary Fellow of the American Medical Writers Association, a Life Member of the Australasian Society of Clinical and Regulatory Scientists (ARCS), an Editorial Board Member for the Research Integrity and Peer Review journal, and is the only author from the Asia Pacific region on the international Good Publication Practice for Communicating Company-Sponsored Research (GPP3) guidelines and the Joint Position Statement on the Role of Professional Medical Writers. Karen is regularly invited to present her research and share her insights at major international and regional conferences.